Wright Medical Group N.V. (WMGI)
| Market Cap | 3.90B |
| Revenue (ttm) | 820.47M |
| Net Income (ttm) | -110.04M |
| Shares Out | 129.46M |
| EPS (ttm) | -0.86 |
| PE Ratio | n/a |
| Forward PE | 72.46 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | Nov 12, 2021 |
| Last Price | $29.98 |
| Previous Close | $29.98 |
| Change ($) | 0.00 |
| Change (%) | 0.00% |
| Day's Open | - |
| Day's Range | 29.83 - 30.72 |
| Day's Volume | 0 |
| 52-Week Range | 23.14 - 30.74 |
News
Merger Arbitrage Analysis And Spread Performance - September 20, 2020
Transitional Pass-Through Payment Reimburses Hospital Outpatient and Ambulatory Surgical Centers for Incremental Cost of AUGMENT in Hindfoot and Ankle Fusion Procedures
Mayo Clinic Performs First-Ever Shoulder Procedure Utilizing 3-D, Holographic Views Displayed by Mixed Reality System Mayo Clinic Performs First-Ever Shoulder Procedure Utilizing 3-D, Holograp...
Wright Medical (WMGI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wright Medical (WMGI) reported earnings 30 days ago. What's next for the stock?
Some of the biggest medical device companies' stocks have dropped to attractive prices due to the current COVID-19 pandemic.
Wright Medical (WMGI) is gaining traction from strong international presence and robust product portfolio. However, adverse forex continues to raise concerns.
Wright Medical Group (NASDAQ: WMGI), a medical device maker that caters to the orthopedic market, saw its stock rally by over 30% on Monday, after news emerged that it would be acquired by lar...
Final Trades: Guidewire, Corteva, Shake Shack and more
The "Halftime Report" traders give their top stocks to watch for the second half
Optimistic investors sent the major benchmarks to record levels.
Shares jump after the company accepts a buyout offer.
Wright Medical Group N.V. (NASDAQ: WMGI) shares exploded on Monday after the announcement that the firm would be acquired by Stryker Corp.
Stryker announced a $4 billion plan to acquire Wright Medical Group on Monday — sending the two medical technology stocks on a divergent path in premarket trading on the stock market.
Shares of Wright Medical Group N.V. WMGI, +5.82% rocketed 32% toward a 3-month high in premarket trading Monday, after the medical device company announced an agreement to be bought out by Str...
AMSTERDAM, The Netherlands, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI) today announced that it has entered into a definitive agreement under which Stryker (NYSE...
Wright Medical (WMGI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Strong international footprint, solid prospects in the global orthopedic space and an enhanced product pipeline bode well for Wright Medical (WMGI). However, adverse forex mars prospects.
Abandoning toxic stocks at the right time is the key to safeguard your portfolio from big losses.
Company to Showcase CARTIVA® Synthetic Cartilage Implant, PROstep ™ Minimally Invasive Surgery System, Total Ankle Continuum of Care and AUGMENT® Injectable Bone Graft
Generally overhyped toxic stocks are susceptible to outside shocks. Moreover, these stocks are loaded with a high level of debt.
Wright Medical's reported results weren't bad, but Cartiva and core foot revenues both disappointed and management lowered expectations by more than 3%.
President and CEO of Wright Medical Group Nv (30-Year Financial, Insider Trades) Robert J Palmisano (insider trades) bought 46,654 shares of WMGI on 08/12/2019 at an average price of $21.39 a ...
Wright Medical Group stock collapsed to a 15-month low Thursday after the medical devices implant company slashed its 2019 sales guidance on slower-than-expected second-quarter revenue. The p...
Wright Medical (WMGI) gains from Upper and Lower Extremities units in Q2; slashes 2019 view.
Wright Medical Group NV (WMGI) CEO Robert Palmisano on Q2 2019 Results - Earnings Call Transcript
Wright Medical (WMGI) delivered earnings and revenue surprises of 100.00% and -1.62%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Wright Medical (WMGI) continues to benefit from strong international sales, new product launches and solid prospects in the global Orthopedic space.
Wright Medical (WMGI) reported earnings 30 days ago. What's next for the stock?
U.S. companies have begun to respond to President Donald Trump's proposed tariffs on Mexican imports with mixed comments on the effects they would have on them and their customers.
Wright Medical (WMGI) Q1 results benefit from higher revenues, solid show by Lower as well as Upper Extremities segments and gross margin expansion. However, rising costs remain a woe.
Wright Medical Group N.V. (WMGI) CEO Bob Palmisano on Q1 2019 Results - Earnings Call Transcript
Wright Medical delivers a strong, no-drama quarter with acceleration across all the major businesses.
Wright Medical (WMGI) delivered earnings and revenue surprises of 66.67% and 1.57%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Wright Medical (WMGI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wright Medical (WMGI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
These top-ranked stocks are likely to beat on the bottom line in their next release.
About WMGI
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. It also provides sports medic... [Read more...]
| Industry Medical Devices | Founded 1999 |
| CEO Robert J. Palmisano | Employees 3,030 |
| Stock Exchange NASDAQ | Ticker Symbol WMGI |
Financial Performance
In 2019, WMGI's revenue was $920.90 million, an increase of 10.13% compared to the previous year's $836.19 million. Losses were -$114.23 million, -32.61% less than in 2018.